Free Chat Friday (Every Friday) -- Our live chat room with stock and option alerts! Fridays, starting at 9:30 am, go to: https://goo.gl/O3l5KC use the password: freechatfriday
Biogen Inc.(NASDAQ : BIIB)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Loading BIIB News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.26%||68.40||0.9%||$507.16m|
|REGN||Regeneron Pharmaceuticals, Inc.||5.27%||385.96||2.7%||$326.45m|
|VRTX||Vertex Pharmaceuticals Incorporated||-0.43%||116.92||1.9%||$290.29m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.28%||126.56||1.9%||$240.65m|
|NBIX||Neurocrine Biosciences, Inc.||-0.71%||53.21||5.3%||$113.72m|
|BMRN||BioMarin Pharmaceutical Inc.||-0.73%||95.56||4.5%||$110.21m|
|KITE||Kite Pharma, Inc.||-0.94%||81.86||16.6%||$95.33m|
|A||Agilent Technologies, Inc.||-1.06%||54.84||1.5%||$88.67m|
|CLVS||Clovis Oncology, Inc.||-1.86%||57.13||18.1%||$81.62m|
Biogen, Inc. is a global biotechnology company, which focuses on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. Its products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, and FAMPYRA for multiple sclerosis, ALPROLIX for hemophilia B and ELOCTATE for hemophilia A. The company also collaborates on the development and commercialization of RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA which is approved for the treatment of chronic lymphocytic leukemia. Biogen was founded by Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.